Greetings MESO members,
I am owner and operator of Thane labs. We are a US domestic only source with an emphasis on testing and transparency. Our original reason for starting this lab was simply to circumvent the inconsistency of UGLs and thus ascertain quality lab tested gear for our own personal use only. As time passed and knowledge grew, I came to realize that not only could we match but often times surpass the quality of brew put out by some of the most highly acclaimed UGLs we are aware of. It was on the heels of this recognition that the transmutation from private endeavor to public enterprise began and eventually came to fruition. Instead of senselessly talking further I will instead cut to the information applicable to my membership here at MESO.
Quality assurance and quality control are what I emphasize above all else. Every batch of raws is submitted for qualitative analysis (mass spec) before the brewing process ever begins. Dosing is adjusted based on results of the aforementioned analyses to provide as close to an accurately dosed product as possible under the limitations of this system. I want our clients to be able to run our gear without fear or hesitation, knowing that what they receive with each new order will be of virtually identical quality to the last. No grossly under dosed gear, no blaming our suppliers, no excuses. Quality will always fluctuate slightly as this is unavoidable for an UGL, but the fluctuation will be exactly that – slight.
Our intention was to make labels across the board an accurate representation of the amount of active pharmaceutical ingredient (API) actually contained in a given product – NOT simply of the amount of raw material used regardless of purity. We do believe this has been achieved.
However, this has proven problematic for a select few short estered compounds, namely NPP, which simply cannot be brewed to achieve an accurate “standard” labeled dosage of 100mg/mL of API without the use of nasty PIP inducing solvents to hold undesirably high concentrations in suspension. Transparency such as this, to the extent possible, is how we intend to operate for better or worse. We contend that the negatives of withholding or concealing pertinent information from our customers far outweigh any potential positives, both morally and fiscally for all parties involved.
In order to both keep ourselves honest and the end user informed, we have taken a slightly un-orthodox approach to brewing and labeling. Firstly, you will notice lower concentrations than what would perhaps be “average” for an UGL listed on our products both short and long esters alike. That is to make sure there is enough “room” to attain the actual or very close to the actual labeled dosage of active pharmaceutical ingredient (API) in each product without causing the user any issues whatsoever. You will NOT need mega-dosages to grow here! Certain product labels have been altered from the “standard” dosages the UGL market is used to seeing where necessary, which you will be able to see in our product list. There is a small margin of error due to the inherent inaccuracies of the type of mass spectrometry testing we have secured privately, but it is likely no more than +/- 5%. We aim to end up slightly over rather than under.
I’ve provided an example to illustrate how reasonably accurate dosing is achieved for those who may be confused as to what exactly the above entails. Let’s presume a given batch of Testosterone Enanthate tests at 90% purity.
To obtain a dosage of about 250mg/mL of active pharmaceutical ingredient (API) the following amount of raw material would be used per mL
278mg x .90 (representing purity) = 250.2mg/mL API
It’s that simple. Purity values of raws used will fluctuate within an acceptable margin, but NEVER will “bunk” or grossly underdosed product be sold. Raws that do not fall within this accepted margin have been and will continue to be disposed of.
I am owner and operator of Thane labs. We are a US domestic only source with an emphasis on testing and transparency. Our original reason for starting this lab was simply to circumvent the inconsistency of UGLs and thus ascertain quality lab tested gear for our own personal use only. As time passed and knowledge grew, I came to realize that not only could we match but often times surpass the quality of brew put out by some of the most highly acclaimed UGLs we are aware of. It was on the heels of this recognition that the transmutation from private endeavor to public enterprise began and eventually came to fruition. Instead of senselessly talking further I will instead cut to the information applicable to my membership here at MESO.
Quality assurance and quality control are what I emphasize above all else. Every batch of raws is submitted for qualitative analysis (mass spec) before the brewing process ever begins. Dosing is adjusted based on results of the aforementioned analyses to provide as close to an accurately dosed product as possible under the limitations of this system. I want our clients to be able to run our gear without fear or hesitation, knowing that what they receive with each new order will be of virtually identical quality to the last. No grossly under dosed gear, no blaming our suppliers, no excuses. Quality will always fluctuate slightly as this is unavoidable for an UGL, but the fluctuation will be exactly that – slight.
Our intention was to make labels across the board an accurate representation of the amount of active pharmaceutical ingredient (API) actually contained in a given product – NOT simply of the amount of raw material used regardless of purity. We do believe this has been achieved.
However, this has proven problematic for a select few short estered compounds, namely NPP, which simply cannot be brewed to achieve an accurate “standard” labeled dosage of 100mg/mL of API without the use of nasty PIP inducing solvents to hold undesirably high concentrations in suspension. Transparency such as this, to the extent possible, is how we intend to operate for better or worse. We contend that the negatives of withholding or concealing pertinent information from our customers far outweigh any potential positives, both morally and fiscally for all parties involved.
In order to both keep ourselves honest and the end user informed, we have taken a slightly un-orthodox approach to brewing and labeling. Firstly, you will notice lower concentrations than what would perhaps be “average” for an UGL listed on our products both short and long esters alike. That is to make sure there is enough “room” to attain the actual or very close to the actual labeled dosage of active pharmaceutical ingredient (API) in each product without causing the user any issues whatsoever. You will NOT need mega-dosages to grow here! Certain product labels have been altered from the “standard” dosages the UGL market is used to seeing where necessary, which you will be able to see in our product list. There is a small margin of error due to the inherent inaccuracies of the type of mass spectrometry testing we have secured privately, but it is likely no more than +/- 5%. We aim to end up slightly over rather than under.
I’ve provided an example to illustrate how reasonably accurate dosing is achieved for those who may be confused as to what exactly the above entails. Let’s presume a given batch of Testosterone Enanthate tests at 90% purity.
To obtain a dosage of about 250mg/mL of active pharmaceutical ingredient (API) the following amount of raw material would be used per mL
278mg x .90 (representing purity) = 250.2mg/mL API
It’s that simple. Purity values of raws used will fluctuate within an acceptable margin, but NEVER will “bunk” or grossly underdosed product be sold. Raws that do not fall within this accepted margin have been and will continue to be disposed of.
